We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,113 hedge funds and large institutions have $48.7B invested in Thermo Fisher Scientific in 2016 Q4 according to their latest regulatory filings, with 141 funds opening new positions, 388 increasing their positions, 434 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more first-time investments, than exits

New positions opened: 141 | Existing positions closed: 55

7% more funds holding

Funds holding: 1,0441,113 (+69)

1.33% less ownership

Funds ownership: 88.67%87.34% (-1.3%)

11% less repeat investments, than reductions

Existing positions increased: 388 | Existing positions reduced: 434

12% less capital invested

Capital invested by funds: $55.2B → $48.7B (-$6.44B)

35% less funds holding in top 10

Funds holding in top 10: 9360 (-33)

46% less call options, than puts

Call options by funds: $123M | Put options by funds: $228M

Holders
1,113
Holders Change
+69
Holders Change %
+6.61%
% of All Funds
27.82%
Holding in Top 10
60
Holding in Top 10 Change
-33
Holding in Top 10 Change %
-35.48%
% of All Funds
1.5%
New
141
Increased
388
Reduced
434
Closed
55
Calls
$123M
Puts
$228M
Net Calls
-$105M
Net Calls Change
-$130M
Name Holding Trade Value Shares
Change
Change in
Stake
BVDMP
701
Bedrijfstakpensioenfonds Voor De Media PNO
Netherlands
$1.19M
NO
702
Ninety One
South Africa
$1.18M
TNBTD
703
Trustmark National Bank Trust Department
Mississippi
$1.17M +$68.3K +463 +6%
ACS
704
Archford Capital Strategies
Illinois
$1.17M -$100K -680 -8%
NAM
705
NTV Asset Management
West Virginia
$1.15M
HCM
706
Highbridge Capital Management
New York
$1.14M +$1.19M +8,046 New
WSA
707
Wall Street Associates
California
$1.13M
HTC
708
Haverford Trust Company
Pennsylvania
$1.12M +$47K +319 +4%
DIA
709
Denver Investment Advisors
Colorado
$1.11M -$893K -6,059 -43%
Pacer Advisors
710
Pacer Advisors
Pennsylvania
$1.11M -$50.1K -340 -4%
PAMG
711
Patton Albertson Miller Group
Tennessee
$1.11M -$41.3K -280 -3%
BCM
712
BlueCrest Capital Management
Jersey
$1.11M +$619K +4,198 +114%
MCM
713
Manchester Capital Management
Vermont
$1.09M
Los Angeles Capital Management
714
Los Angeles Capital Management
California
$1.08M -$15M -101,825 -93%
BO
715
Bank OZK
Arkansas
$1.06M -$39.8K -270 -3%
PA
716
Parallel Advisors
California
$1.06M +$1.11M +7,524 New
AP
717
Advisor Partners
California
$1.06M +$20.8K +141 +2%
LIM
718
Leavell Investment Management
Alabama
$1.05M
AIMCA
719
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$1.04M +$1.09M +7,400 New
Northwestern Mutual Wealth Management
720
Northwestern Mutual Wealth Management
Wisconsin
$1.04M -$229K -1,556 -17%
BOTW
721
Bank of the West
California
$1.04M +$68K +461 +7%
TMAM
722
Tokio Marine Asset Management
Japan
$1.03M -$422K -2,863 -28%
PCA
723
Peddock Capital Advisors
Massachusetts
$1.03M +$107K +726 +11%
TU
724
TDAM USA
Ontario, Canada
$1.02M -$55.3K -375 -5%
BIC
725
Bridges Investment Counsel
Nebraska
$1.02M +$1.07M +7,235 New

TMO Hedge Fund Activity: Q4 2016 in Review

1,113 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2016, worth a combined $48.7B — down 12% from $55.2B a quarter earlier.

Buyers outnumbered sellers: 141 funds opened new TMO positions and 55 closed out — a net gain of 86 holders — while 388 added to existing stakes and 434 trimmed.

The largest buyer was Generation Investment Management, adding an estimated $246M. The largest seller was T. Rowe Price Associates, cutting an estimated $845M.

  • 1,113 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2016, up from 1,044 in Q3 2016.
  • Funds reported $48.7B of Thermo Fisher Scientific stock for Q4 2016, down 12% quarter-over-quarter.
  • 141 funds opened new Thermo Fisher Scientific positions in Q4 2016 and 55 closed out, a net change of +86 holders.
  • The largest Thermo Fisher Scientific buyer in Q4 2016 was Generation Investment Management, an estimated $246M added.
  • The largest Thermo Fisher Scientific seller in Q4 2016 was T. Rowe Price Associates, an estimated $845M sold.

Based on aggregated 13F filings for Q4 2016.